G. A. Bohmig, F. Eskandary, K. Doberer, and P. F. Halloran, The therapeutic challenge of late antibody-mediated kidney allograft rejection, Transpl Int, 2019.

D. Chittka, Early diagnosis and treatment of subclinical ABMR is vital for improving clinical outcomes, Transplantation, 2019.

S. Parajuli, J. E. Alagusundaramoorthy, S. Blazel, J. Aziz, F. Garg et al., Subclinical antibody mediated rejection after kidney transplantation: treatment outcomes, Transplantation, 2019.

R. A. Montgomery, A. Loupy, and D. L. Segev, Antibody-mediated rejection: new approaches in prevention and management, Am J Transplant, vol.3, pp.3-17, 2018.

M. Eikmans, E. M. Gielis, K. J. Ledeganck, J. Yang, D. Abramowicz et al., Non-invasive biomarkers of acute rejection in kidney transplantation: novel targets and strategies, Front Med (Lausanne), vol.5, p.358, 2018.

J. J. Friedewald, S. M. Kurian, R. L. Heilman, T. C. Whisenant, E. D. Poggio et al., Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant, Am J Transplant, vol.19, issue.1, pp.98-109, 2019.

S. Christakoudi, M. Runglall, P. Mobillo, T. L. Tsui, C. Duff et al., Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples, EBioMedicine, vol.41, pp.571-83, 2019.

J. M. O'callaghan and S. R. Knight, Noninvasive biomarkers in monitoring kidney allograft health, Curr Opin Organ Transplant, vol.24, issue.4, pp.411-416, 2019.

E. Van-loon, S. Gazut, and S. Yazdani, Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: a multicentre, prospective study, pp.30463-30466, 2019.